Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company, announced the launch of Ryaltris - AZ Nasal Spray for the treatment of moderate to severe allergic rhinitis, in India. Glenmark being one of the leaders in respiratory segment, has been the first to launch the branded generic version at an affordable cost for the treatment of allergic rhinitis in India. This will provide patients a far more convenient, cost effective treatment option in the country.
- Read more about Glenmark launches Ryaltris AZ at an affordable price in India
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2021/glenmark-launches-ryaltris-az-at-an-affordable-price-in-india
No comments:
Post a Comment